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Abstract
Background: Smoking and physical inactivity are major risk factors for heart disease. Linking strategies that
promote improvements in fitness and assist quitting smoking has potential to address both these risk factors
simultaneously. The objective of this study is to compare the effects of two exercise interventions (high intensity
interval training (HIIT) and lifestyle physical activity) on smoking cessation in female smokers.
Method/design: This study will use a randomised controlled trial design. Participants: Women aged 18–55 years
who smoke ≥ 5 cigarettes/day, and want to quit smoking. Intervention: all participants will receive usual care for
quitting smoking. Group 1 - will complete two gym-based supervised HIIT sessions/week and one home-based
HIIT session/week. At each training session participants will be asked to complete four 4-min (4 × 4 min) intervals
at approximately 90 % of maximum heart rate interspersed with 3- min recovery periods. Group 2 - participants
will receive a resource pack and pedometer, and will be asked to use the 10,000 steps log book to record steps and
other physical activities. The aim will be to increase daily steps to 10,000 steps/day. Analysis will be intention
to treat and measures will include smoking cessation, withdrawal and cravings, fitness, physical activity, and
well-being.
Discussion: The study builds on previous research suggesting that exercise intensity may influence the
efficacy of exercise as a smoking cessation intervention. The hypothesis is that HIIT will improve fitness and
assist women to quit smoking.
Australian New Zealand Clinical Trials Registry: ACTRN12614001255673 (Registration date 02/12/2014)
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Background
Tobacco smoking is a major cause of cardiovascular dis-
ease, chronic obstructive pulmonary disease and many
cancers. In women, research has shown that between the
ages of 18 to 55 years, the largest population risk for
heart disease is attributable to smoking (particularly in
young women) and physical inactivity [1]. Despite steady
declines in smoking prevalence over the past thirty
years, in 2011–12, 16 % (1.4 million) of Australian
women aged 18 years and over smoked daily. The 2009
National Preventative Health Strategy calls for a target
of 10 % or less for smoking prevalence by 2020. This
target will not be reached unless rates of cessation sub-
stantially increase [2]. More than half of all smokers
want to quit [3], but many struggle to achieve abstin-
ence, and relapse is common, with only 5 % of smokers
who quit without any assistance still abstinent at
6 months [4]. As many smokers cite ‘wanting to get fit’
as a motivation for quitting [5], linking strategies that
will simultaneously promote improvement in fitness and
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assist quitting has the potential to change both behav-
iours simultaneously [6].
There is evidence for a positive effect of exercise when
quitting smoking [7], with physical activity (PA) reducing
cigarette cravings and withdrawal symptoms [8]. How-
ever, the evidence for the efficacy of PA as an aid to quit-
ting smoking is mixed. A recent systematic review of 15
randomised controlled trials highlighted insufficient ex-
ercise intensity as a potential limitation of interventions
tested in previous trials which did not improve smoking
abstinence rates [7].
High Intensity Interval Training (HIIT) could over-
come the potential limitation of insufficient intensity, by
providing alternating short bursts of high intensity exer-
cise with recovery periods of light exercise. HIIT pro-
vides rapid physiological adaptations, as indicated by
improvements in maximal oxygen uptake (VO2max), an-
aerobic threshold and stroke volume [9, 10].
Aims
The aims of this project are to: (1) compare the effects
of two exercise interventions (HIIT and a ’10,000 steps’
pedometer based intervention) combined with usual care
smoking cessation support, on cessation rates in female
smokers who wish to quit; (2) assess the effects of HIIT
and 10,000 steps interventions on weight change and (3)
assess whether improvements in fitness, vitality and
intrinsic motivation are mediators of the relationship be-
tween activity and smoking cessation.
Methods
Design, participants and recruitment
The study has received ethical approval from the
Medical Research Ethics Committee of The University
of Queensland (#2014001266). This study will use a two
group randomised controlled trial design. Inclusion and
exclusion criteria are provided in Table 1. Women aged
18–55, smoking at least five cigarettes a day, and who
identify as being willing and ready to make a quit
attempt will be recruited. Recruitment will be from the
local population using radio and print media, advertis-
ing, and through collaborations with local health ser-
vices. A phone number, study email and website will be
available for interested participants to contact the
research team. A member of the research team will
follow-up with a phone call to screen for eligibility,
explain the main requirements of the study, and send
the Participant Information and Consent Form (PICF). If
women wish to participate they will be invited to attend
a screening/baseline visit (Fig. 1) and sign the PICF be-
fore any data are collected.
Randomisation, allocation and concealment
Participants who complete baseline measures will be
randomised into one of two groups: 1) HIIT or 2)
10,000 steps (Fig. 1). Each participant will be random-
ized into one of the two study conditions according to
an allocation sequence generated by a computer pro-
gram and concealed within sealed opaque sequentially
numbered envelopes. Analyses will adjust for any base-
line differences, consistent with standard procedures.
Participants will be allocated to conditions one-at-a-
time, allowing for a “rolling start” to the intervention.
Intervention
Usual care cessation support: Participants in both groups
will receive usual care smoking cessation support, based
on the Smoking Cessation Guidelines for Australian
General Practice [11] This includes a quit pack (available
from Quitline), which covers planning and preparing to
quit, strategies for quit success, and coping with crav-
ings. Participants will also be directed to other resources,
including the ‘My QuitBuddy’ mobile app, and the web-
based QuitCoach. These resources provide personalized
quit plans, monitor progress and money saved, and
motivation and support from others using the app. Par-
ticipants will also be directed to call Quitline should they
wish to speak to a counsellor about their quit attempt.
Quitline is a confidential service with a professional
advisor available for counseling and advice on quit-
ting smoking.
10,000 steps pedometer group: participants assigned to
this group will receive a resource pack and pedometer,
and will be asked to increase their daily steps to 10,000.
The resource pack contains a log-book to record steps/
day, number of cigarettes smoked, and hints and tips for
increasing step counts. The log-book is based on re-
sources used by the Queensland 10,000 steps project
(www.10000steps.org.au) Trained research staff will
phone these participants once a week to check and
Table 1 Inclusion/exclusion criteria
Inclusion criteria Exclusion criteria
Women aged 18 to 55 years Currently using pharmacological
quit smoking aids
Currently smoking at least
5 cigarettes per day
Medical problems that increase risk
of adverse events during exercise
(including unstable angina, pulmonary
disease, uncontrolled hypertension,
cardiomyopathty, orthopaedic or
neurological limitations)
Desire to quit smoking Planned surgery during research period
Willing to attend the gym
twice weekly if allocated
to HIIT intervention group
Current or planned pregnancy
Drug or alcohol abuse
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record pedometer use and discuss barriers and strategies
for successfully increasing PA.
HIIT group: participants assigned to this group will
complete two gym-based supervised sessions (supervised
by trained research staff ) and one home-based HIIT ses-
sion each week. The HIIT protocol will be completed by
fast walking or running on a treadmill with the deck
inclined to reach the desired intensity, or on a cycle erg-
ometer if individuals are unable or do not wish to use
the treadmill. The 35 min protocol consists of: warm-up
at 65 % of heart rate maximum (HRmax) (5 min); 4 ×
4 min intervals at 85–95 % HRmax (with the target zone
reached by at least two minutes), interspersed with
3 min recovery at 65 % HRmax; and cool down (5 min),
with a total exercise time of 35 min (see Fig. 2). Attend-
ance at supervised sessions and adherence to home-
based sessions (including compliance with target heart
rate) will be monitored and recorded by research staff.
After the 12-week intervention researcher support will
be removed from both groups (e.g. removal of supervised
HIIT sessions and 10,000 steps support). Researcher con-
tact will only be made to arrange and complete follow-up
measures during weeks 13 and 26.
Data collection
Participants will be assessed on three occasions: at base-
line, week 13 and week 26 (see Fig. 1). Cigarettes per
day will be measured weekly. Withdrawal symptoms,
cigarette cravings and feelings of stress, will be moni-
tored during the intervention. See Table 2 for full list of
measures, and measurement time-points. Exercise and
fitness measures will be completed by research staff
whom will be blinded to participant group allocation.
Smoking measures
Smoking abstinence and cessation will be assessed using
the Russell Standard [12]. This includes self-reported
‘quitting’ (not smoking for two weeks) and expelled car-
bon monoxide concentration (Micro Smokerlyser; Pico
simple, Harrietsham, UK) of less than 10 ppm (which
reflects abstinence from smoking during the previous
24-h). Saliva will be collected by drooling into a 50 ml
Falcon tube. The sample will be frozen and stored for
analysis of cotinine, which is a metabolite of nicotine.
Self-reported number of cigarettes smoked will be re-
corded each week. Withdrawal symptoms and cravings
will be assessed using the Mood and Physical Symptoms
Fig. 1 Flow of study
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Scale (MPSS) [13]. Smoking dependency will be assessed
using the Fagerström Test for Nicotine Dependance
(FTND) [14]. Subjective stress will be assessed using
the 4-item Perceived Stress Scale (PSS) to monitor
any changes associated with smoking reduction or in-
creasing PA [15].
Exercise, fitness and physical activity measures
Cardiorespiratory fitness (VO2max) will be assessed
using a graded exercise test to exhaustion. We will ana-
lyse expired air using a metabolic system (Trueone 2400,
Sandy, USA) to calculate the maximal rate of oxygen
consumed and used during the test. We will monitor
participants’ ECG (CASE, Milwaukee, USA) during
and after the test. Maximal heart rate attained will be
used to determine the training intensity for each
participant. We will measure blood pressure prior to
and during the test.
This fitness test will be completed on a treadmill
(T2100, Little Chalfont, UK) or a cycle ergometer (Lode
Excalibur Sport, Groningen, Netherlands) if individuals
are unable or do not wish to use the treadmill. The tread-
mill test will use a ramp protocol where the inclination is
constant (5.5 %) and the speed increased 0.5 km/h every
minute, starting at 4 km/h. The cycle protocol includes a
2 × 4 min warm-up at 25 W and 50 W. The test starts at
50 W and increases by 25 W every minute. We will ask
participants to refrain from smoking two hours before
the test, and from drinking alcohol, or doing any vig-
orous or moderate intensity activities 12-h before the test.
Lung function will be assessed by forced vital capacity
[FVC], forced expiratory volume in 1 s [FEV1] and
Table 2 Timeline for data collection
Measurement time-point
Measures Baseline Week 2 Week 4 Week 8 Week 13 Week 26
Cigarettes per day (weekly)
Smoking cessation X X
Withdrawal symptoms X X X X X X
Cigarette cravings X X X X X X
Cigarette dependence X X X
Subjective stress X X X X X
Saliva cotinine X X X
Cardiorespiratory fitness X X X
Lung function X X X
Body composition X X X
Physical activity X X X
Well-being X X X
Motivation X X X
Demographic information X X X
Cool down 
5:00 3:00 3:00 3:00 5:00
4:00 4:00 4:004:00
Warm up 3 minute walks in 
between at 65%HRmax 
4 x 4 minutes at 85-95% HRmax  
(walking/running up an incline) 
Fig. 2 Example of a 35 min 4 × 4 HIIT session
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FEV1/FVC ratio, using a Vitalograph (2150, Ennis,
Ireland). We will ask participants to inhale completely
and rapidly through the mouth (not the nose), then
exhale maximally and forcefully, with their lips creating
an airtight seal around the mouthpiece, until no more
air can be expelled (minimum of six seconds). Partici-
pants will repeat the manoeuvre three times, with a rest
period of ≥1 min between efforts. Peak expiratory flow
rate [PEFR]) will be assessed using a portable peak flow
meter (Assess, Cedar Grove, USA), using the same tech-
nique as described above. Participants will repeat the
manoeuvre three times, with a rest period of ≥1 min be-
tween efforts.
Body composition will be assessed by researcher mea-
sured body mass index (height, weight), and waist
circumference. Standing height and weight will be mea-
sured using a stadiometer (SECA 217-172-1009, Hamburg,
Germany) and electronic scale (Charder MS 3200,
Hamburg, Germany) respectively. Waist circumference
will be measured using a tape passed around the nar-
rowest point of the abdomen. We will take each measure
twice and use the average measure obtained, unless the
first and second measures vary by more than 1 %, in
which case we will use the median of three measure-
ments. Body mass index will be calculated as weight (kg)/
height2 (m2).
Physical activity and sedentary time will be measured
using a wrist-worn GENEActiv accelerometer, which will
be worn for one week at each measurement time. The
GENEActiv is a tri-axial, ± 6 g seismic acceleration
sensor. It is small (36x30x12 cm), lightweight (16 g),
waterproof, and offers a near body temperature sensor
to help improve the confirmation of wear and non-time.
GENEActivs will be configured with a sampling fre-
quency of 80 Hz, with data uploaded and converted to
15 s epoch .csv files using GENEActiv PC software ver-
sion 2.1. We will import the epoch files into custom
built Excel spreadsheets that will compute the most
likely posture (lying, sitting, standing, ambulation), activ-
ity intensity (sedentary, light, moderate, vigorous) and
sleep. This will provide information on average daily
sedentary, active and sleep patterning and behaviour,
and will provide a measure of overall weekly physical
activity. GENEActiv validity studies have demonstrated
strong correlations for criterion validity (r = 0.79 to 0.98)
for physical activity and sedentary behaviour [5, 6]. Data
in this study will be based on standard criteria for wear
time [7].
Demographic information
Participants will complete a baseline survey with rele-
vant repeated questions at weeks 13 and 26. The surveys
will include questions on age, education, occupation,
income, health history, and smoking history.
Self-reported health and behaviour
Well-being will be measured with the SF36 (physical
and mental summary scores and eight subscales (in-
cluding vitality) [16]. Motivation will be assessed with
the Behavioural Regulation in Exercise Questionnaire
(BREQ-2) [17].
Data analysis
The aim of this study is to obtain data on the effects of
HIIT training on smoking cessation and intermediate
outcomes, such as cigarette cravings and withdrawal
symptoms. Using effect size estimates based on results
of a previous study using vigorous PA for smoking cessa-
tion in women (i.e. OR = 2.09, [18]), adopting a two
tailed alpha level of 0.05 and power 0.80, a sample size
of 100 will be required. Based on funding and time
constraints, the study aims to recruit 50 participants per
group. Descriptive statistics will be used to summarize
the characteristics of participants in each group, and to
describe those who successfully quit. Yates’ corrected
Chi-squared test will be used to analyse the difference in
the proportions who quit in each group, and changes in
categorical (e.g. smoking abstinence) and continuous
(e.g. number of cigarettes smoked) variables will be
assessed using generalised linear modeling.
Discussion
Physical inactivity and tobacco smoking are important
contributors to the overall burden of disease in
Australia, and are significant risk factors for almost all
Australia’s major non-communicable physical and men-
tal health problems.
This study is innovative, as it will build on suggestions
from previous studies that intensity of exercise may be a
critical factor in determining the efficacy of PA interven-
tions for smoking cessation. Our study addresses this
issue by comparing the effect of two PA interventions of
varying intensity on smoking cessation outcomes.
In examining the notion that HIIT (combined with a
quit program) will result in higher quit rates than a
more moderate PA intervention, we will also examine
novel mediators (fitness, vitality and intrinsic motiv-
ation) which will improve understanding of the relation-
ships between HIIT and smoking cessation.
Further, we will assess the effect of exercise intensity on
other indicators of smoking, such as withdrawal symp-
toms, cigarette cravings and weight gain, as these factors
are important barriers to smoking cessation. This project
will address the weaknesses of previous studies (e.g. poor
assessment of intensity, adherence or compliance to exer-
cise) and is novel in design and conceptualisation.
HIIT has potential to impact on individual cardio-
vascular health and to be a very cost effective interven-
tion, compared with other cardiovascular treatments
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(e.g. statins), as it may address two major contribu-
tors to cardiovascular disease (smoking and physical
inactivity) in one intervention. The research will in-
form efforts to develop novel, innovative, and time ef-
ficient strategies for promoting cardiovascular health
in women.
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